NCT02433041View on ClinicalTrials.gov

Baden Prevention and Reduction of Incidence of Postoperative Delirium Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

December 21, 2018

Study Completion Date

December 21, 2018

Conditions
Postoperative Delirium
Interventions
DRUG

Haloperidol

Haloperidol 0.005mg/kg at induction of anesthesia

DRUG

Ketamine

Ketamine 1mg/kg at induction of anesthesia to test its power to prevent postoperative delirium

DRUG

Haloperidol + Ketamine

Haloperidol 0.005mg/kg + Ketamine 1mg/kg at induction of anesthesia to test their power to prevent postoperative delirium if given together

DRUG

Saline solution (NaCl 0.9%)

Placebo being used in one of the four groups

Trial Locations (1)

4031

University Hospital Basel, Basel

All Listed Sponsors
collaborator

Kantonsspital Baden

OTHER

lead

University Hospital, Basel, Switzerland

OTHER

NCT02433041 - Baden Prevention and Reduction of Incidence of Postoperative Delirium Trial | Biotech Hunter | Biotech Hunter